Carlos Alemany

1.5k citations
40 papers · 671 indexed · h-index 15

Carlos Alemany

39 papers receiving 652 citations

Peers

Carlos Alemany
Comparison fields: 5 of 84
  • Oncology 411
  • Pathology and Forensic Medicine 83
  • Pulmonary and Respiratory Medicine 143
  • Cancer Research 61
  • Genetics 39
Replace Shuncong Wang with:
Shuncong Wang China
Fausto Meriggi Italy
Diana P. English United States
Elona Juozaitytė Lithuania
N. W. Peacock United States
Parvin F. Peddi United States
Ross Jennens Australia
Corey Pelletier United States
K. Swenerton Canada
Yingwei Qi United States
Carlos Alemany relative to Shuncong Wang China Shuncong Wang's profile →
Citations per field
00.5×10×20×30×39×
Shuncong Wang · 1×
Citations per year

Countries citing papers authored by Carlos Alemany

Since Specialization
Citations

This map shows the geographic impact of Carlos Alemany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Alemany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Alemany more than expected).

Fields of papers citing papers by Carlos Alemany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Alemany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Alemany. The network helps show where Carlos Alemany may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carlos Alemany, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carlos Alemany Line = papers co-authored together Carlos Alemany links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20241
3 20237
4 20224
5 202217
6 20213
7 20205
8 20199
9 201926
10 20146
11 201412
12 20145
13 201320
14 201243
15 201110
16 201047
17 200551
18 200425
19 200428
20 200374

About Carlos Alemany

Carlos Alemany is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 40 papers that have together received 671 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (9 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (8 papers), Lung Cancer Research Studies (7 papers), Estrogen and related hormone effects (4 papers), Economic and Financial Impacts of Cancer (4 papers), Breast Cancer Treatment Studies (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (411 citations), Pathology and Forensic Medicine (83 citations) and Pulmonary and Respiratory Medicine (143 citations). Carlos Alemany has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Toni K. Choueiri, Rony M. Abou-Jawde, Tarek Mekhail, Eric D. Hsi, Paul Elson, Brad Pohlman, Thomas H. Cartwright, Ji‐Hyun Lee, Guillermo Abesada‐Terk and R. H. Brown. Their work appears in journals such as Journal of Clinical Oncology, Journal of Oncology Practice, Cancer Research, Annals of Oncology and Clinical Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026